A clinical study to see the efficacy of bhunimbadi churna in prameha purvarupa with special reference to prediabetes.
Phase 2
- Conditions
- Health Condition 1: R730- Abnormal glucose
- Registration Number
- CTRI/2024/07/070227
- Lead Sponsor
- DR Deepika Suryawanshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Age between 21 years to 70 years.
2 Gender - All
3 Subject who are willing to give written informed consent.
4 Patients having signs and symptoms of Prameha purvarupa like Swedatipravritti, Pipasa, Angasada, Nidradhikya and Karapadatala daha.
5 Newly diagnosed with Prediabetes
6 HbA1C 5.7-6.4%
7 BSL Fasting 110-125mg/dl
8 BSL PP140-199 mg/dl
Exclusion Criteria
1 Prior use of medicine to treat diabetes.
2 Pregnant and lactating women.
3 Patients having complications like CKD, HIV, CA, acute conditions of CHD.
4 Patients who are immunocompromised and who are on immunosuppressant medications.
5 Those patients who are not ready to comply the trial protocol.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method